Previous close | 1.0200 |
Open | 1.0000 |
Bid | 1.0600 x 1000 |
Ask | 1.2100 x 1200 |
Day's range | 0.9800 - 1.0800 |
52-week range | 0.8800 - 7.7200 |
Volume | |
Avg. volume | 102,677 |
Market cap | 18.764M |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.2630 |
Earnings date | 10 Aug 2022 - 15 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.75 |
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of 13.73% and 40.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ARDS, CNNE, EXK, GP, and IFF have been added to the Zacks Rank #5 (Strong Sell) List on November 15, 2021.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...